Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing and Disclosure Requirements) Regulations, 2015, as amended ,(''Listing Obligations''), read with para A ....

Corporate Relationship Department BSE Limited Phiroze Jeejeebhoy Towers Dalal Street, Fort, Mumbai – 400 001 Maharashtra, India Scrip Name : Earkart Limited Scrip Code : 544549 ISIN : INE1A8F01035 Subject : Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 – Intimation of Incorporation of Subsidiary Dear Sir / Madam, Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, (‘Listing Regulations’), read with Para A of Part A of Schedule III of Listing Regulations and SEBI Master Circular No. HO/49/14/14(7)2025- CFD-POD2/P/CIR/2026/3762 dated 30 January 2026, we would like to inform that a foreign subsidiary (subsidiary) of the Company has been incorporated in the United Kingdom as per the Certificate of Incorporation issued on 08 June 2026. The relevant details as required under the SEBI Listing regulation read with SEBI master circular No. HO/49/14/14(7)2025-CFD-POD2/P/CIR/2026/3762 dated 30 January 2026 are provided in Annexure A, enclosed herewith. The same will be made available on the Company's website https://www.earkart.in This is for your information, records and appropriate dissemination. Thanking You. Yours faithfully, For Earkart Limited (formerly known as “Earkart Private Limited”) Preeti Srivastava Company Secretary & Compliance Officer Membership No: A31615 Date : 22 June 2026 Place : Noida Annexure A Disclosure under Para A of Part A of Schedule III read with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Sr. No. Particulars Information a. Name of the target entity, details in brief Name: Earkart Health Limited such as size, turnover etc. Authorised Share Capital: GBP 10,000/- (Great British Pound Ten Thousand) Paid up Share Capital: GBP 10,000/- (Great British Pound Ten Thousand) The Company holds 650 equity shares of GBP 10 each, constituting 65% of the paid-up share capital of EarKart Health Limited. Turnover: NIL, being a newly incorporated company. b. Whether the acquisition would fall within Upon incorporation, Earkart Health related party transaction(s) and whether Limited has become a subsidiary of the the promoter/ promoter group/ group Company and consequently a related companies have any interest in the party of the Company in accordance entity being acquired? If yes, nature of with the applicable provisions of the interest and details thereof and whether Companies Act, 2013 and the SEBI the same is done at “arm’s length” Listing Regulations. Except as stated above, the Promoters, Promoter Group and Group Companies have no interest in the transaction c. Industry to which the entity being Healthcare acquired belongs d. Objects and impacts of acquisition The subsidiary has been incorporated (including but not limited to, disclosure to provide healthcare services and sell of reasons for acquisition of target healthcare products and other related entity, if its business is outside the main products. line of business of the listed entity) The business of the subsidiary is not outside the main line of business of the Company. e. Brief details of any governmental or No governmental or regulatory regulatory approvals required for the approvals were required for the acquisition incorporation, other than the registration formalities completed with the relevant authorities in the United Kingdom. f. Indicative time period for completion of The subsidiary has already been the acquisition incorporated on 08 June 2026. g. Nature of consideration – whether cash Subscription to initial paid-up share consideration or share swap and details capital of GBP 6500/- (Great British of the same Pound Six Thousand Five Hundred) by the Company is in cash. h. Cost of acquisition or the price at which At face value of GBP 10/- (Great the shares are acquired British Pound Ten) per share. i. Percentage of shareholding/ control The Company has subscribed to 650 acquired and/ or number of shares equity shares of GBP 10 each, acquired representing 65% of the paid-up share capital of Earkart Health Limited. j. Brief background about the entity Earkart Health Limited was acquired in terms of products/line of incorporated on 08 June 2026 in the business acquired, date of incorporation, United Kingdom. The company has history of last 3 years turnover, country been incorporated to undertake in which the acquired entity has healthcare services, healthcare presence and any other significant products and allied activities. Since it information (in brief) is a newly incorporated entity, turnover details for the last three years are not applicable. The company currently does not have any business operations.